Giulia C. Kennedy, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 18,162 shares at $34.39 ($629K) on 2021-06-04, disclosed to the SEC on 2021-06-08.
Open-market sale of $629k VCYT by Chief Scientific & Med Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.28 | 1,507 | $50K | 8.0% |
| 2 | $33.28 | 1,507 | $50K | 8.0% |
| 3 | $34.39 | 2,595 | $89K | 14.2% |
| 4 | $34.39 | 2,595 | $89K | 14.2% |
| 5 | $35.17 | 4,979 | $175K | 27.8% |
| 6 | $35.17 | 4,979 |
| $175K |
| 27.8% |
| Total | $34.63 avg | 18,162 | $629K | 100% |
| Filing → |
| VCYT | SELL | 2022-11-08 | $26K | — | Filing → |
| VCYT | SELL | 2022-08-09 | $27K | — | Filing → |
| VCYT | SELL | 2022-03-09 | $1.0M | — | Filing → |